mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |